EyeDura Therapeutics

Private

New York City, New YorkHealthcare & Life Scienceshttps://eyedura.com/

Company Overview

EyeDura Therapeutics Inc. is a biotechnology company developing preservative-free topical sustained-release eye drops that target both anterior and posterior segment diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

sustained-release eye dropsdrug delivery platformophthalmic drug deliveryneurotrophic keratitisNKbiotech companyorphan drugrare eye diseasedrug depotTopical Sustained ReleaseTSRpreservative-free eye dropsclinical-stage pharmapatient compliancedry eye diseaseage-related macular degenerationlife cycle management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EyeDura Therapeutics Comparables

Compare EyeDura Therapeutics with similar companies based on industry and business-model similarity.

EyeDura Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
BIOPHTA	70%
INEYE THERAPEUTICS S.A.	65%
Dompé	64%

View all Comparables

EyeDura Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

EyeDura Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

EyeDura Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EyeDura Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Year Founded2024

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?